PDT and PIT induce significant cell death and survival signalling (e.g. EGFR activation, VEGF secretion [64–66], priming cancer cells for concurrent molecular-targeted therapy (e.g. cetuximab), resulting in synergistic tumour reductions [59, 61, 67]. Here, EGFR is linked to cancer.